Q2 2019 Milestone Pharmaceuticals Inc Earnings Call Transcript
Good day, ladies and gentlemen, and welcome to the Milestone Pharmaceuticals midyear 2019 regulatory update call. As a reminder, this call is being recorded.
I would now like to introduce your host for today's conference, Eleanor Barisser.
Thank you, operator. Good morning and thank you for joining us for our midyear regulatory update conference call. Delivering prepared remarks on today's call will be Joseph Oliveto, President and Chief Executive Officer. Joining Joe for the Q&A session will be Dr. Francis Plat, Chief Medical Officer; Lorenz Muller, Chief Commercial Officer; and Tim Maness, Vice President of Finance.
Please note that the focus of today's call will be the etripamil program regulatory update announced this morning. For an overview of Milestone's second-quarter financial results, we ask that you please refer to this morning's press release or 10-Q filing.
This is Milestone's first conference call since the closing of the Company's IPO in
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |